Premium
Balloon‐occluded retrograde transvenous obliteration for the treatment of gastric varices
Author(s) -
Dadabhai Alia S.,
Fenkel Jonathan M.,
Brown Daniel B.,
Laine Loren
Publication year - 2012
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.25635
Subject(s) - gastric varices , balloon , medicine , varices , radiology , cirrhosis
CLINICAL PERSPECTIVES IN HEPATOLOGY aims to engage two experts with opinions supporting differing perspectives on the management of a case. Typically, the case represents an area of debate or evolving practice in clinical hepatology. The patient presented below gives us the opportunity to discuss balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices. Although described since the mid-1990s and accepted as effective therapy, particularly in Japan, BRTO is Fig. (A) Baseline axial MRI demonstrates multiple prominent gastric fundal varices (white arrows). (B) Coronal images from the same study demonstrate occlusive thrombus in the main (white arrow), and left and right (arrowheads) portal vein branches. (C) With the balloon inflated (white arrow), the sclerosing agent fills the gastrorenal shunt (white arrowhead) and the gastric varices (black arrow). (D) CT scan obtained 3 months after the procedure demonstrates resolution of the varices with residual sclerosant in the veins (white arrow).